Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Cullinan Therapeutics, Inc.(CGEM) | 7,648,268 | 7,648,268 | 0 | $128.03M | $93.16M | 13.23% | -$34.88M |
| Crinetics Pharmaceuticals Inc. | 525,845 | 617,035 | +91,190 | $26.87M | $31.55M | 4.48% | +$4.68M |
| Edgewise Therapeutics, Inc.(EWTX) | 917,166 | 1,079,316 | +162,150 | $24.48M | $28.82M | 4.09% | +$4.34M |
| Insmed Incorporated(INSM) | 615,391 | 389,611 | -225,780 | $44.92M | $26.90M | 3.82% | -$18.02M |
| Natera, Inc.(NTRA) | 177,099 | 160,626 | -16,473 | $22.48M | $25.43M | 3.61% | +$2.94M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 492,723 | 589,579 | +96,856 | $19.22M | $24.38M | 3.46% | +$5.16M |
| Disc Medicine, Inc.(IRON) | 311,761 | 346,401 | +34,640 | $15.32M | $21.96M | 3.12% | +$6.64M |
| Lantheus Holdings, Inc.(LNTH) | 150,182 | 236,213 | +86,031 | $16.48M | $21.13M | 3.00% | +$4.65M |
| Zai Lab Limited(ZLAB) | 0 | 800,000 | +800,000 | $0 | $20.95M | 2.97% | +$20.95M |
| Avidity Biosciences Inc | 688,975 | 702,981 | +14,006 | $31.64M | $20.44M | 2.90% | -$11.20M |
| Iovance Biotherapeutics, Inc.(IOVA) | 2,406,714 | 2,673,905 | +267,191 | $22.60M | $19.79M | 2.81% | -$2.81M |
| PTC Therapeutics, Inc.(PTCT) | 89,715 | 434,767 | +345,052 | $3.33M | $19.63M | 2.79% | +$16.30M |
| Wave Life Sciences, Inc.(WVE) | 624,471 | 1,489,237 | +864,766 | $5.12M | $18.42M | 2.62% | +$13.30M |
| Scholar Rock Holding Corporation(SRRK) | 0 | 416,144 | +416,144 | $0 | $17.99M | 2.55% | +$17.99M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 349,063 | 315,230 | -33,833 | $17.60M | $17.07M | 2.42% | -$530.1K |
| Olema Pharmaceuticals, Inc.(OLMA) | 2,680,596 | 2,912,550 | +231,954 | $32.01M | $16.98M | 2.41% | -$15.03M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 329,733 | 391,018 | +61,285 | $18.32M | $16.45M | 2.34% | -$1.87M |
| Context Therapeutics Inc.(CNTX) | 0 | 14,705,882 | +14,705,882 | $0 | $15.44M | 2.19% | +$15.44M |
| Guardant Health, Inc.(GH) | 499,170 | 452,739 | -46,431 | $11.45M | $13.83M | 1.96% | +$2.38M |
| Revolution Medicines, Inc.(RVMD) | 291,391 | 313,817 | +22,426 | $13.21M | $13.73M | 1.95% | +$511.8K |
| iTeos Therapeutics, Inc. | 1,745,943 | 1,745,943 | 0 | $17.83M | $13.41M | 1.90% | -$4.42M |
| Cartesian Therapeutics, Inc.(RNAC) | 629,423 | 721,139 | +91,716 | $10.15M | $12.92M | 1.83% | +$2.77M |
| Rocket Pharmaceuticals, Inc.(RCKT) | 1,066,373 | 1,020,559 | -45,814 | $19.70M | $12.83M | 1.82% | -$6.87M |
| Akero Therapeutics Inc | 392,544 | 460,617 | +68,073 | $11.26M | $12.81M | 1.82% | +$1.55M |
| Trevi Therapeutics, Inc.(TRVI) | 1,538,517 | 3,094,896 | +1,556,379 | $5.14M | $12.75M | 1.81% | +$7.61M |
| Twist Bioscience Corporation(TWST) | 294,930 | 267,497 | -27,433 | $13.32M | $12.43M | 1.76% | -$894.4K |
| Compass Therapeutics, Inc.(CMPX) | 5,641,894 | 8,567,896 | +2,926,002 | $10.38M | $12.42M | 1.76% | +$2.04M |
| Janux Therapeutics, Inc.(JANX) | 171,105 | 230,000 | +58,895 | $7.77M | $12.31M | 1.75% | +$4.54M |
| Replimune Group, Inc.(REPL) | 0 | 950,000 | +950,000 | $0 | $11.50M | 1.63% | +$11.50M |
| Nuvation Bio Inc.(NUVB) | 0 | 4,164,178 | +4,164,178 | $0 | $11.08M | 1.57% | +$11.08M |
| Vera Therapeutics, Inc.CL A(VERA) | 0 | 257,788 | +257,788 | $0 | $10.90M | 1.55% | +$10.90M |
| IDEAYA Biosciences, Inc.(IDYA) | 0 | 414,035 | +414,035 | $0 | $10.64M | 1.51% | +$10.64M |
| Relay Therapeutics, Inc.(RLAY) | 2,033,041 | 2,268,825 | +235,784 | $14.39M | $9.35M | 1.33% | -$5.05M |
| United Therapeutics Corporation(UTHR) | 0 | 23,000 | +23,000 | $0 | $8.12M | 1.15% | +$8.12M |
| Arcturus Therapeutics Holdings Inc.(ARCT) | 219,508 | 459,943 | +240,435 | $5.09M | $7.81M | 1.11% | +$2.71M |
| Xenon Pharmaceuticals Inc.(XENE) | 165,800 | 197,212 | +31,412 | $6.53M | $7.73M | 1.10% | +$1.20M |
| Stoke Therapeutics, Inc.(STOK) | 479,452 | 685,826 | +206,374 | $5.89M | $7.56M | 1.07% | +$1.67M |
| Aquestive Therapeutics Inc | 1,796,750 | 1,611,833 | -184,917 | $8.95M | $5.74M | 0.81% | -$3.21M |
| Axsome Therapeutics, Inc.(AXSM) | 0 | 50,000 | +50,000 | $0 | $4.23M | 0.60% | +$4.23M |
| Sutro Biopharma, Inc.(STRO) | 2,832,064 | 2,160,062 | -672,002 | $9.80M | $3.97M | 0.56% | -$5.82M |
| Werewolf Therapeutics, Inc.(HOWL) | 2,388,011 | 2,388,011 | 0 | $5.06M | $3.53M | 0.50% | -$1.53M |
| Design Therapeutics, Inc.(DSGN) | 0 | 559,547 | +559,547 | $0 | $3.45M | 0.49% | +$3.45M |
| Zentalis Pharmaceuticals, Inc.(ZNTL) | 1,465,801 | 1,106,851 | -358,950 | $5.39M | $3.35M | 0.48% | -$2.04M |
| Veru Inc.(VERU) | 0 | 4,285,365 | +4,285,365 | $0 | $2.79M | 0.40% | +$2.79M |
| Adaptimmune Therapeutics plcADR(ADAPY) | 5,095,912 | 5,095,912 | 0 | $4.84M | $2.75M | 0.39% | -$2.09M |
| ALX Oncology Holdings Inc.(ALXO) | 2,409,862 | 1,391,434 | -1,018,428 | $4.39M | $2.32M | 0.33% | -$2.06M |
| Repare Therapeutics, Inc. | 1,639,849 | 1,231,154 | -408,695 | $5.64M | $1.61M | 0.23% | -$4.03M |
| 89Bio Inc | 330,000 | 0 | -330,000 | $2.44M | $0 | — | -$2.44M |
| Intellia Therapeutics, Inc.(NTLA) | 267,557 | 0 | -267,557 | $5.50M | $0 | — | -$5.50M |
| Kalvista Pharmaceuticals Inc | 896,915 | 0 | -896,915 | $10.39M | $0 | — | -$10.39M |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 72,395 | 0 | -72,395 | $15.36M | $0 | — | -$15.36M |
| REGENXBIO Inc.(RGNX) | 50,000 | 0 | -50,000 | $524.5K | $0 | — | -$524.5K |
| Solid Biosciences Inc | 11,518 | 0 | -11,518 | $80.3K | $0 | — | -$80.3K |
| Viking Therapeutics, Inc.(VKTX) | 120,982 | 0 | -120,982 | $7.66M | $0 | — | -$7.66M |